Skip to content

The application of esketamine with subclinical anesthesia dose in intravenous adjuvant in epidural anesthesia for cesarean section

The application of esketamine with subclinical anesthesia dose in intravenous adjuvant in epidural anesthesia for cesarean section

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069946
Enrollment
Unknown
Registered
2023-03-30
Start date
2021-08-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postpartum depression

Interventions

Esketamine group:Cut the peritoneal immediate intravenous escitalopram ketamine 0.15 mg/kg (diluted saline to 5 ml)
Control group:Cut the peritoneal immediate intravenous equal volume normal saline

Sponsors

Wenzhou People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
21 Years to 40 Years

Inclusion criteria

Inclusion criteria: 60 cases of elective singleton primiparous women undergoing cesarean section, inclusion criteria: 1) The results of preoperative fetal umbilical blood flow and fetal monitoring (NST) were normal; 2) The gestational age was 37-41 weeks; 3) ASA I-II 4) Age 21-40 years old;

Exclusion criteria

Exclusion criteria: 1) Patients with contraindications to spinal anesthesia (including coagulation disorders, spinal trauma or deformity, etc.); 2) Patients with elevated blood pressure, intraocular pressure and intracranial pressure; 3) Those who are allergic to ketamine components;

Design outcomes

Primary

MeasureTime frame
Neonatal umbilical cord blood of blood gas analysis and Apgar score;Prenatal and postpartum 42 days of Edinburgh depression scale (EPDS) questionnaire;

Secondary

MeasureTime frame
I-DI;T-DI;U-DI;Vital Signs;VAS;OAA/S;Adverse reaction;

Countries

China

Contacts

Public ContactZheng yanya
zhengxianya@163.com+86 137 5871 9108

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026